Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Regeneron nearly doubles Eylea sales forecast
Reuters
Thursday, April 26, 2012 - 11:13am
tags:
earnings, Regeneron
Earnings Preview: Merck to report on 1Q results
Yahoo/AP
Thursday, April 26, 2012 - 10:54am
tags:
earnings, Merck
Amgen Looking, Thinking, And Acting More Like A Pharma Co.
Seeking Alpha
Thursday, April 26, 2012 - 10:53am
tags:
Amgen, Pfizer, Eli Lilly, Affymax
Mylan, Pfizer Announce Epinephrine-Pen Settlement With Teva
Bloomberg
Thursday, April 26, 2012 - 10:51am
tags:
Pfizer, Teva Pharmaceuticals, Mylan, settlements, epinephrine pens, EpiPen
Amarin Shares Move Higher on Competing Fish Oil Data
TheStreet.com
Thursday, April 26, 2012 - 10:50am
tags:
Amarin, fish oil, Omthera, Epanova, AMR101
Eli Lilly and Company Earnings Call Nuggets: Gross Margins, Alimta O.U.S.
Wall St. Cheat Sheet
Thursday, April 26, 2012 - 10:49am
tags:
earnings, Alimta, Eli Lilly
Boardroom Revolt at AstraZeneca
Motley Fool
Thursday, April 26, 2012 - 9:29am
tags:
AstraZeneca, David Brennan
AstraZeneca CEO to step down as Q1 profit falls 44 pct; generics cut into Seroquel sales
Yahoo/AP
Thursday, April 26, 2012 - 9:28am
tags:
David Brennan, earnings, AstraZeneca
Bristol-Myers Q1 profit up 12 pct. as sales rise
Yahoo/AP
Thursday, April 26, 2012 - 9:28am
tags:
earnings, Bristol-Myers Squibb
New J&J CEO plans realistic, optimistic future
Yahoo/AP
Thursday, April 26, 2012 - 9:27am
tags:
JNJ, Pharma CEOs, Alex Gorsky
FTC Loses Appeal in Androgel ‘Pay-for-Delay’ Patent Case
Bloomberg Businessweek
Thursday, April 26, 2012 - 9:26am
tags:
pay-for-delay, FTC, Androgel, patents, Solvay
Carl Icahn Plays Nice With Amylin; Shares Jump
WSJ Online
Wednesday, April 25, 2012 - 3:40pm
tags:
Amylin, Carl Icahn
Pfizer Experimental Drug Reduces Autism Signs in Mouse Study
Bloomberg
Wednesday, April 25, 2012 - 3:39pm
tags:
autism, Pfizer, GRN-529
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Wednesday, April 25, 2012 - 3:38pm
tags:
Incivek, Vertex, hepatitis C, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Gilead, Merck, Pfizer
AstraZeneca Amarin-to-Forest Deal Seen on Lost Patents: Real M&A
Bloomberg
Wednesday, April 25, 2012 - 10:32am
tags:
Amarin, Forest Labs, patents, M&A, AstraZeneca, Ardea
Yet Another Delay for Forest Labs
Yahoo/Zacks
Wednesday, April 25, 2012 - 10:31am
tags:
Forest Labs, Ironwood Pharmaceuticals, linaclotide, irritable bowel syndrome
Botox ingredient has limited effect on headaches -study
Reuters
Wednesday, April 25, 2012 - 10:30am
tags:
Botox, migraines, Allergan
Glaxo Quarterly Profit Misses Estimates on Europe Sales
Bloomberg
Wednesday, April 25, 2012 - 10:28am
tags:
GSK, earnings
Amgen buying Turkish pharmaceutical company Mustafa Nevzat Pharmaceuticals for $700 million
Yahoo/AP
Wednesday, April 25, 2012 - 10:27am
tags:
Mustafa Nevzat, Turkey, Amgen, M&A
Lpath Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab
Yahoo
Wednesday, April 25, 2012 - 10:26am
tags:
Lpath, patents, anti-LPA antibodies, Lpathomab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.